Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
News article20 September 2024European Medicines Agency1 min read

Survey on the role and impact of ENCePP

Man working on computer with sand clock

As per the ENCePP workplan (Objective 3), a qualitative research study on the role and impact of ENCePP is being conducted by Shar Rao, Master’s student at Utrecht University (UU), under the supervision of Helga Gardarsdottir, ENCePP Steering Group co-chair. The survey is part of a larger study that includes interviews with stakeholders across Europe. 

The ENCePP Secretariat would would like to ask you to complete the survey until 14 October 2024. It contains questions regarding your use of, and experience with ENCePP, and should take approximately 10 minutes to complete. The questions cover ENCePP in general, and the ENCePP Toolkit (Code of Conduct, Seal, Checklist for Study Protocols, and the Guide on Methodological Standards in Pharmacoepidemiology). All answers will be anonymous, and data will be stored at the UU under the responsibility of the UU Data Manager. 

The results are expected to provide a deeper understanding of the current and future standing of ENCePP, and help define a path forward for the network in its mission to bring together capacity and expertise in pharmacoepidemiology and pharmacovigilance across Europe and develop methodological standards and governance principles. 

Please feel free to share the survey link with anyone whose participation you think may be relevant. For any questions: s [dot] n [dot] raoatstudents [dot] uu [dot] nl (s[dot]n[dot]rao[at]students[dot]uu[dot]nl)

The time and input of all ENCePP Partners to contribute to this research is highly appreciated. Results will be discussed during the ENCePP Plenary on 22 November 2024.

Details

Publication date
20 September 2024
Author
European Medicines Agency